Neural-tube defect risk assessment for individual pregnancies using alphafetoprotein and acetylcholinesterase test results.

AUTOR(ES)

Strike, P W

RESUMO

Pregnancies at risk of being associated with (open) neural tube defects can be identified by maternal serum and amniotic-fluid alphafetoprotein (AFP) concentrations in excess of established screening cut-off valves in conjunction with the results of an amniotic fluid electrophoretic acetylcholinesterase screening test. The risk associated with the AFP cut-off values are formulated in terms of a population screening programme. These "population risks" are of little value in the assessment of test results from individual "at-risk" pregnancies, especially when the observed AFP concentrations are in proximity to the "cut-off" values. A complete risk assessment procedure for individual pregnancies is described and presented in graphical form to permit immediate access by clinical staff.

Documentos Relacionados

• Medical genetics: advances in brief: Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation
• Sib risk of neural tube defect: is prenatal diagnosis indicated in pregnancies following the birth of a hydrocephalic child?
• CT genotype increases the risk of neural tube defect
• Congenital hydrocephalus in two pregnancies following the birth of a child with a neural tube defect: aetiology and management.
• Should women at high risk of neural tube defect have an amniocentesis?